Valproate Safety Programme · Portsmouth

Valproate Safety Programme in Portsmouth.

Pharmacist-owned valproate safety programme — annual PPP review, ARAF documentation and prescribing change support, with audit-ready evidence. Delivered to Portsmouth PCNs and GP practices from the BCS Chiswick (West London) hub, with paired cover from our Halifax (West Yorkshire) hub — the only UK dual-hub clinical pharmacy model.

Portsmouth · local context

Portsmouth PCNs sit within NHS Hampshire and Isle of Wight ICB.

Portsmouth PCNs cover one of the south coast's most deprived urban patches — pharmacist programmes lean on CVD optimisation and high-risk drug monitoring.

For valproate safety specifically, the Portsmouth pathway typically integrates with Portsmouth Hospitals University NHS Trust (Queen Alexandra). BCS standardises the cross-organisation workflow into a single hub-supervised process.

What you get

What valproate safety in Portsmouth actually looks like.

  • Annual Pregnancy Prevention Programme review
  • ARAF documentation
  • Contraception counselling and signposting
  • Prescribing change support
  • Audit-ready evidence pack

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every valproate safety placement in Portsmouth is mobilised from one of our two clinical hubs — Chiswick (West London) as the lead and Halifax (West Yorkshire) as paired cover. The dual-hub model is unique to BCS: same SOPs, same supervision, same-week cross-cover.

  • Lead delivery from the BCS Chiswick (West London) hub
  • Paired cover from BCS Halifax (West Yorkshire)
  • Same-week sickness, leave and maternity cover
  • ARRS-compliant, GPhC-registered workforce
  • One SLA, one report, one escalation point

Portsmouth · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Portsmouth
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Portsmouth PCNs choose BCS for valproate safety.

Solo recruitment for valproate safety in Portsmouth leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Chiswick (West London)/Halifax (West Yorkshire) dual-hub.

Frequently asked questions — Valproate Safety Programme in Portsmouth.

Does this meet the MHRA valproate requirements?+

Yes — the BCS valproate programme is designed against the current MHRA Pregnancy Prevention Programme requirements.

Does BCS already deliver valproate safety in Portsmouth?+

BCS supports PCNs across South East from our Chiswick (West London) hub with paired cover from Halifax (West Yorkshire), and is actively delivering or available to mobilise valproate safety in Portsmouth. Get in touch and we'll confirm current capacity.

How quickly can BCS mobilise valproate safety in Portsmouth?+

In most cases inside 4–6 weeks of contract sign-off, with HSCN-secured remote prescribing back-up available sooner where capacity is urgent.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call